{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:49:50Z","timestamp":1775645390419,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":5570,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1111\/j.1600-6143.2007.01910.x","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T10:30:14Z","timestamp":1184841014000},"page":"2106-2113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":372,"title":["Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"7","author":[{"given":"A.","family":"Asberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Humar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rollag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mouas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D","family":"Pescovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sgarabotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.L.","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2007.01910.x_bib1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ\u2010transplant recipients","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/00003495-200565060-00012","article-title":"Valganciclovir: A review of its use in the management of CMV infection and disease in immunocompromised patients","volume":"65","author":"Cvetkovic","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-6135.2004.00727.x","article-title":"Cytomegalovirus","volume":"4","author":"Green","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/17460794.1.2.147","article-title":"Valganciclovir: What is the status in solid organ transplantation?","volume":"1","author":"Pescovitz","year":"2006","journal-title":"Future Virology"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/00912709922008452","article-title":"Single\u2010dose pharmacokinetics of valganciclovir in HIV\u2010 and CMV\u2010seropositive subjects","volume":"39","author":"Jung","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib8","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00003088-200544050-00003","article-title":"Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients","volume":"44","author":"Wiltshire","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00042560-200208010-00004","article-title":"A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis","volume":"30","author":"Lalezari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib13","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/JCM.38.6.2122-2127.2000","article-title":"Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: Clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients","volume":"38","author":"Caliendo","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/342601","article-title":"Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid\u2010organ transplant patients with CMV disease","volume":"186","author":"Humar","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1469-0691.2002.00449.x","article-title":"Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients","volume":"8","author":"Rollag","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/00007890-200010270-00007","article-title":"A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients","volume":"70","author":"Sagedal","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1086\/375194","article-title":"Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir","volume":"187","author":"Razonable","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/425905","article-title":"Kinetics of cytomegalovirus load decrease in solid\u2010organ transplant recipients after preemptive therapy with valganciclovir","volume":"191","author":"Mattes","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib19","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1111\/j.1600-6143.2006.01488.x","article-title":"Monitoring of human cytomegalovirus\u2010specific CD4 and CD8 T\u2010cell immunity in patients receiving solid organ transplantation","volume":"6","author":"Gerna","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bmt.1705311","article-title":"Oral valganciclovir as pre\u2010emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients","volume":"37","author":"Van Der Heiden","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib21","first-page":"77","article-title":"Management of CMV infection and disease in transplant patients. 27\u201329 February 2004","volume":"11","author":"Razonable","year":"2004","journal-title":"Herpes"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00007890-199901150-00016","article-title":"Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney\u2010pancreas transplant recipients","volume":"67","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00007890-199304000-00031","article-title":"Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid\u2010organ transplant recipients","volume":"55","author":"Van Den Berg","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/315242","article-title":"Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation","volume":"181","author":"Sia","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/377002","article-title":"Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid\u2010organ\u2010transplant recipients with CMV disease","volume":"188","author":"Humar","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2007.01910.x_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.icb.7100013","article-title":"The inter\u2010play between host and viral factors in shaping the outcome of cytomegalovirus infection","volume":"85","author":"Scalzo","year":"2007","journal-title":"Immunol Cell Biol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2007.01910.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522145223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522145223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2007.01910.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:42:23Z","timestamp":1761626543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522145223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1600613522145223"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01910.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01910.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}